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Abstract
Background: The synthesis of sex steroids is controlled by several enzymes such as17α-hydroxylase cytochrome
P450 (P450c17) catalyzing androgen synthesis and aromatase cytochrome P450 (P450arom) catalyzing estrogen
synthesis, both of which must complex with the redox partner NADPH-cytochrome P450 oxidoreductase (CPR) for
activity. Previous studies have identified expression of steroidogenic enzymes in vaginal tissue, suggesting local sex
steroid synthesis. The current studies investigate P450c17, P450aromatase and CPR expression in vaginal mucosa of
Galea spixii (Spix cavy) by immuno-histochemical and western immunoblot analyses.
Methods: Stages of estrous cyclicity were monitored by vaginal exfoliative cytology. After euthanasia, vaginal
tissues were retrieved, fixed and frozen at diestrus, proestrus, estrus and metestrus. The ovaries and testis were
used as positive control tissues for immunohistochemistry.
Results: Data from cytological study allowed identification of different estrous cycle phases. Immunohistochemical
analysis showed different sites of expression of steroidogenic enzymes along with tissue response throughout different
phases of the estrous cycle. However, further studies are needed to characterize the derived hormones synthesized by,
and the enzymes activities associated with, vaginal tissues.
Conclusion: Current results not only support the expression of enzymes involved in sex steroid synthesis in the wall of
the vagina, they also indicate that expression changes with the stage of the cycle, both the levels and types of cells
exhibiting expression. Thus, changes in proliferation of vaginal epithelial cells and the differentiation of the mucosa may
be influenced by local steroid synthesis as well as circulating androgens and estrogens.
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Background
Galea spixii (Spix cavy) are rodents of the Caviidae family
and subfamily Caviinae [1] that live in backland vegetation
of the Brazilian northeastern region [2]. Most animals are
bred in captivity for food [3, 4], in part to help preserve the
species which is on the endangered list of the International
Union of Conservation of Nature [5]. Spix cavy has also
been employed as experimental models in research on pla-
cental function [2, 6]. Based on vaginal exfoliative cytology,
the estrous cycle lasts 14–19 days and the vaginal epi-
thelium undergoes variations related to each estrous cycle
phases [4] in concert with ovarian follicular development
and ovulation [7].
Laboratory rodents including mice, rats and guinea
pigs are commonly used as experimental models since
they have a relatively short estrous cycle and gestation
length, and are easy to handle [8–11]. Guinea pigs
(Cavia porcellus), like Spix cavy were employed in some
of the earliest studies elucidating morphological and
physiological changes in the reproductive tract and vagina
during reproductive cyclicity [12–15]. Moreover, the
biology of the vaginal mucosa has clinical significance.
For instance, atrophy of the vaginal epithelium in post-
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menopausal women can have serious consequences for
quality of life [16] requiring therapies aimed at restor-
ing estrogenic stimulation lost as a result of decreased
ovarian synthesis [17]. Though many treatment strat-
egies employ local application of estrogens themselves
[18], others have found success using dehydroepian-
drosterone (DHEA) [19]. DHEA has little bioactivity of
its own, but seems to provide benefits similar to estro-
gens [19], suggesting it may be used as a substrate for
estrogen synthesis in the vaginal wall itself. Indeed, data
has been reported that supports this possibility, specif-
ically demonstrating the expression of steroidogenic
enzymes in the vaginal epithelium [16, 20–22].
Therefore, the current investigation was undertaken to
begin to define changes in the vaginal mucosa of Spix
cavy and the potential expression of key steroidogenic
enzymes such as 17α-hydroxylase/17,20-lyase (P450c17)
[23, 24]; and aromatase (P450arom) [25, 26]; cytochromes
P450 that are required for androgen and estrogen synthe-
sis respectively.
Methods
Animals
Twelve adult (>6 months of age) females (n = 3 at each
phase of the estrous cycle) were housed in outside enclo-
sures (2.5 × 2.5 m wide; 2.2 m high) and fed a variety of
fruits, grass, maize grains and a commercial rabbit diet
with access to water ad libitum.
All were reared in captivity at the Wild Animals
Multiplication Center of the Universidade Federal Rural
do Semiárido, campus Mossoró RN Brazil (IBAMA
2028236/2008). Animal care and use conformed to pro-
tocols approved by the Committee of Bioethics of the
Faculty of Veterinary Medicine and Animal Science of
the Universidade de São Paulo (Protocol 2400/2011).
Exfoliative vaginal cytology
Reproductive cycles were monitored using exfoliative va-
ginal cytology. Vaginal smears were collected daily with
sterile cotton swabs and the biological material was de-
posited on glass slides stained with panoptic fast test,
following instructions by the manufacturer (Laborclin®,
Vargem Grande/Pinhais PR Brazil). Two full cycles were
monitored for each animal prior to euthanasia and tissue
collection, analyzed and photodocumented by light micros-
copy. The predominant cells in each smear were classified
as superficial, large and small intermediate, parabasal and
neutrophils throughout the cycle. Then the estrous cycles
phases were characterized according the different cell types
present in each phase [4, 7, 12, 13].
Collection of material for immunohistochemistry
At each stage of the estrous cycle (estrus, metestrus, dies-
trus and proestrus), females were anesthetized with xylazine
hydrochloride (4 mg/kg/IM) plus ketamine hydrochloride
(60 mg/kg/IM) and then euthanized with sodium thiopen-
tal (2.5% 60 mg/kg). After euthanasia, the genital organs
were then exposed and samples of tissues from the vaginal
tube were retrieved in each phase of the cycle along with
ovaries used as positive control tissue. Vaginal tissues were
fixed in 4% buffered paraformaldehyde. Samples were
dehydrated (ethanol series, from 50 to 100%), diaphanized
in xylol and paraffin embedded. Additional tissue samples
for western blotting were frozen at -80 °C.
Immunohistochemistry
Tissue sections (5 μm, Leica RM2165) were placed in
buffer at 70 °C for 3 h, diaphanized in xylol, re-hydrated
and rinsed with distilled water, then heated at 90 °C
immersed in a buffer citrate solution in a micro-oven.
Endogenous peroxidase activity was blocked by hydro-
gen peroxide (H2O2, 3%) and blocked with normal horse
serum (Vector Labs, Burlingame, CA, USA). Sections
were incubated with primary antisera raised against
P450arom anti-rabbit/mouse (1/400- ab18995, Abcam,
Cambridge, MA, USA), NADPH-cytochrome P450 oxido-
reductase (CPR) anti-mouse, rat, sheep, rabbit, guinea pig,
hamster, cow, dog, human, pig, monkey (1/200- ab13513,
Abcam, Cambridge, MA, USA), and P450c17 (1/200- Dr.
Alan J. Conley, UC, Davis, California, USA), for 16 h. The
primary antiserum was omitted for negative controls. Sec-
tions were rinsed, incubated with secondary anti-mouse/
rabbit antisera ready-to-use (Immpress Universal Kit™,-
Vector Labs, Burlingame CA USA) followed by amplifier
solution and developed with DAB (ImmPACT™ DAB, Vec-
tor Labs, Burlingame, CA USA). Sections were counter-
stained with hematoxylin and mounted with coverslips.
Images were captured with camera Olympus UTVO.5XC
mounted on an Olympus BX61VS light microscope.
Western immuno-blotting
The specificity of staining for P450c17 was verified by
western immuno-blotting. Tissues were homogenized
using a Polytron PT 3000 KINEMATICATM (Brinkman,
Westbury, USA) in a hypotonic lysis buffer containing
50 mM potassium phosphate (pH 7.0), 0.3 M sucrose,
0.5 mM dithiothreitol (DTT), 1 mM ethylenediaminetetra-
acetic acid (EDTA, pH 8.0), 0.3 mM phenylmethylsulfonyl
fluoride (PMSF), 10 mM NaF and phosphatase inhibitor
cocktail (1: 100; Sigma-Aldrich). Protein concentration in
homogenates was determined using Bradford’s method
[27] according to the manufacturer (Protein Assay Kit;
BIORAD, CA USA) and using albumin as a standard.
Proteins (50ug) were denatured with Laemmli buffer
(15% glycerin, 0.05 M Tris, 0.055 M bromophenol blue,
9% SDS) with 6% beta-mercaptoethanol (1:1), heated
at 95 °C for 5 min. Proteins were resolved on one-
dimensional SDS–PAGE minigels. The separated proteins
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were electro-transferred to immunoblot polyvinylidene
difluoride membranes (PVDF-Bio-Rad Laboratories), at a
constant current of 120 mA for 2 h, at 4 °C, in Tris-HCl
buffer (Tris-HCl 12.5 mM, glycine, 1% SDS and 20%
methanol). After transfer, the membranes were blocked
with 5% non-fat dried milk in PBS-Tween 1% (PBS-T) for
2 h and incubated with a rabbit primary anti-bovine
P450c17 (1:1000) anti-serum (Dr. Alan J. Conley, UC,
Davis, CA USA) overnight at 4 °C.
On the following day the membranes were incubated
with the secondary antibody anti-rabbit IgG-peroxidase
conjugate (1/2000, BIORAD, CA USA) for 1 h at room
temperature. The proteins were visualized by chemilu-
minescence (CHEMI-DOC®, BIORAD, CA USA) and
images captured using commercial software (Image Lab®
4.01, BIORAD, CA USA). Molecular size of visualized
bands was estimated from a commercial protein size
ladder (Kaleidoscope®, BIORAD, CA USA). Loading
was verified by incubation with a monoclonal mouse
anti-β-actin antibody (Santa Cruz Biotechnology, Santa
Cruz, CA, USA) diluted 1:10.000 in blocking solution
for 2 h at room temperature. Membranes were then in-
cubated with the secondary antibody anti-mouse IgG-
peroxidase conjugate (1:2000, BIORAD, CA USA) for 1 h
at room temperature. The proteins were visualized by
chemiluminescence.
Results
Detecting the phases of the estrous cycle
Vaginal cytology allowed characterization of cycle stage.
Superficial nucleated cells were predominant when sperm
were also evident in the smear in those female co-housed
with males and were therefore a reliable indication of es-
trus. Parabasal cells predominated during metestrus, small
intermediate cells during diestrus which transitioned
into large, superficial intermediate cells during proes-
trus. These changes were consistent from cycle to cycle
and made it possible to predict the onset of estrus.
Immunohistochemistry
The vaginal epithelium was typically stratified squamous
with cell types that correlated with exfoliative cytological
findings, varying among stages: a simple squamous a few
cell layers in thickness during metestrus, a slight acceler-
ation of proliferation and increased thickness during the
diestrus, then, reaching several cell layers in thickness
with cornification of the superficial layers and some loss
of nuclei during proestrus. At estrus, the epithelium
showed only one or a few layers of cornified cells and a
low proliferation of intermediate and parabasal cells.
Expression of P450arom was immunolocalized in cells
of the connective tissue of the lamina propria during
the diestrous phase (Fig. 1A); in the basal cells of the
epithelium during proestrus (Fig. 1B); in basal cells of
the epithelium in estrus (Fig. 1D); and in fewer scat-
tered cells of the connective tissue during metestrus
(Fig. 1C). No immunoreactivity was observed in the
negative controls for the vaginal epithelium (Fig. 1E),
and positive immunoreactivity was confined to the cells
of the granulosa layer of antral follicles in ovarian tissue
sections, further demonstrating specificity in the posi-
tive tissue controls (Fig. 1F).
Expression of P450c17 was detected in a few basal
cells in the vaginal epithelium during diestrus (Fig. 2A);
more superficial, surface cells during proestrus (Fig. 2B);
and in basal cells of the epithelium in estrus (Fig. 2D).
Immunoreactivity in the vaginal epithelial cells was weak
during metestrus (Fig. 2C). No immunoreactivity was
observed in the absence of the primary antisera (Fig. 2E).
Immunoreactivity for P450c17 was restricted only to
Leydig cells of testes (Fig. 2F).
Immunolocalization of CPR indicated expression of
this co-enzyme was present in the epithelium and in the
cells of the connective tissue during diestrus (Fig. 3A); in
the basal cells of the epithelium and in cells of the con-
nective tissue in proestrus (Fig. 3B) and estrus (Fig. 3D);
in the cells of the connective tissue and the epithelium
during metestrus (Fig. 3C). Immunoreactivity was not
detected in the absence of the primary antisera (Fig. 3E).
Immunoreactivity was observed primarily in the Leydig
cells of testes used as positive control (Fig. 3F).
Western immuno-blotting
Western immuno-blotting confirmed the expression of
P450c17 in the vaginal epithelium during proestrus and
estrus, but was not detectable during metestrus or dies-
trus (Fig. 4). Testicles of adult males used for positive
control also were detected. Molecular size for P450c17
was slightly over 52 kDa and for endogenous control β
actin was 42 kDa.
Discussion
Current results not only support the expression of en-
zymes involved in sex steroid synthesis in the wall of the
vagina, they also indicate that expression changes with
the stage of the cycle, both the levels and types of cells
exhibiting expression. Thus, changes in proliferation of
vaginal epithelial cells and the differentiation of the mu-
cosa may be influenced by local steroid synthesis as well
as circulating estrogens. Lephart et al. [20] reported that
aromatase activity in vaginal mucosa of rats was increased
by testosterone. Testosterone is known to increase in
serum and ovarian tissues in mice during proestrus [28],
and vaginal mucosa expresses androgen receptors [16, 21]
at levels that vary with age and menopausal status of
women. Berman et al. [16] reported that the enzyme
5α-reductase which can convert testosterone into dihydro-
testosterone is also expressed in the human vagina. It is
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possible that cycle stage-specific, vaginal expression of ste-
roidogenic enzymes is an androgen-stimulated response.
Furthermore, Iguchi et al. [29] demonstrated that treat-
ment with testosterone, even administered concurrent
with 5α-reductase and aromatase inhibitors, stimulated
epithelial cell proliferation resulting in a marked increased
thickness of the vaginal epithelium in ovariectomized
mice. Therefore, it is likely that vaginal epithelial prolifera-
tion is stimulated directly by androgens.
Given the stimulatory response of vaginal epithelium
to androgens, the possibility that androgen synthesis
might occur locally within the vaginal epithelium itself
assumes additional relevance. To the authors’ know-
ledge, no studies have been reported that examined the
expression of the enzyme P450c17 in the vaginal tissue
of any species. Confirmation that CPR, the redox partner
protein for both P450c17 and P450arom, is also expressed
in this tissue provides further support for local sex steroid
synthesis. Although P450c17 expression in the vaginal
wall of Spix cavy was less evident than aromatase and
cytochrome P450 NADPH reductase, immuno-staining
in positive controls tissues (Leydig cells), together with
the apparent molecular size as expected by western im-
munoblot, supports its presence. Since levels were de-
tectable only during the proestrous and estrous phases,
local synthesis might coincide with vaginal proliferation
and augment the effects of ovarian steroids. Equally,
increased expression during proestrus might reflect
Fig. 1 Immunolocalization of the enzyme cytochrome P450 aromatase in the vaginal epithelium and ovary of Spix cavy. a immunoreactivity in
cells (arrow) of the connective tissue (ct); (e) epithelium in the vaginal wall at diestrus. b immunoreactivity in basal cells (b) of the epithelium in
the vaginal wall (c) cornified cells of the epithelium; (ct) connective tissue in the vaginal wall at proestrus. c immunoreactivity in cells (arrow) of
the connective tissue (ct); (e) epithelium in the vaginal wall at metestrus. d immunoreactivity in basal cells (b) of the epithelium; (c) cornified cells;
(ct) connective tissue in the vaginal wall at estrus. e no immunoreactivity in the epithelium (e) or connective tissue (ct) in the absence of primary
antiserum, negative control. f immunoreactivity in the cells of the granulosa layer (gc) of the ovary tissue; oocyte (o); positive control. Bars = 20 μm
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regulation of P450c17 in vaginal epithelium by ovarian an-
drogens. Further studies must be undertaken to quantify
the levels of enzyme induced and the steroids synthesized.
With regard to the local production of androgens in
the vaginal tissue, Berman et al. [16] reported for the
first time that the enzyme 5α-reductase, which can con-
vert testosterone into dihydrotestosterone, is expressed
in association with androgen receptors in the human va-
gina. The authors also observed that the levels of andro-
gen receptors varied according to age and menopausal
status of women.
Proliferation of the vaginal epithelium is clearly stim-
ulated by estrogens, and probably androgens, but their
effects are modified by progestins [30] in a complex
dose-dependent fashion, highly stimulatory at low levels
but inhibitory at higher doses [31]. In Spix cavy, local
synthesis of estrogens and/or androgen, as implied
by steroidogenic enzyme expression, may induce or
contribute to cyclic epithelial differentiation in vaginal
tissue. Further studies, perhaps using local application
of inhibitors of sex steroid synthesis may reveal the
physiological importance of local steroid production in
vaginal epithelium of Spix cavy, building on results of
past studies in guinea pigs [30] and rats [32].
Effects of vaginal dehydroepiandrostenedione applica-
tion, vaginal testosterone, and tissue selective estrogen
complexes have been promoted as promising new ther-
apies in post-menopausal women; however, further stud-
ies are necessary to confirm their efficacy and safety
[19]. Based on present results, the local synthesis of dehy-
droepiandrostenedione by P450c17 may be considered
in further studies in other species including women. Not-
withstanding potential species differences, Spix cavy may
prove to be an excellent experimental model of relevance in
studies on vaginal biology and health of post-menstrual
women, women treated with aromatase inhibitors [17, 18]
Fig. 2 Immunolocalization of the enzyme cytochrome P450c 17 in the vaginal epithelium, and testes of Spix cavy. a immunoreactivity in basal
cells (arrow) of the epithelium (e); (ct) connective tissue at diestrus. b immunoreactivity in surface cells (arrow) of the epithelium (e); (ct) connective
tissue at proestrus. c immunoreactivity in epithelium cells (arrow); (ct) connective tissue at metestrus. d immunoreactivity (arrow) in basal cells
(b); (c) cornified cells; (ct) connective tissue at estrus. e no immunoreactivity in epithelium cells (e) or connective tissue (ct). Negative control.
f immunoreactivity in Leydig cells of the testicle (arrow). Spermatozoa (arrowhead). Positive control. Bars = 20 μm
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Fig. 3 Immunolocalization of the enzyme NADPH cytochrome P450 reductase in the vaginal epithelium and testes of Spix cavy. a immunoreactivity in
cells (arrow) of the epithelium (e) and connective tissue (ct) at diestrus. Bar = 20 μm. b immunoreactivity in the basal cells of the epithelium (b) and of
the connective tissue (ct); (c) cornified surface cells of the epithelium at proestrus. Bar = 10 μm c immunoreactivity in cells (arrows) of the epithelium
and connective tissue (ct); (c) cornified cells of the epithelium at metaestrus. d immunoreactivity in cells (arrow) of the connective tissue (ct) and basal
cells (b) of the epithelium; cornified cells of the epithelium at estrus e no immunoreactivity in cells of the epithelium (e) or connective tissue (ct).
Negative control. f immunoreactivity in Leydig cells of the testicle (arrow). Spermatozoa (arrowhead). Positive control. Bars = 20 μm
Fig. 4 Western immuno-blotting test for enzyme cytochrome P450c17 in the vaginal tissue of Spix cavy in several phases of the estrous cycle.
Metaestrus (m), diestrus (d), proestrus (p), estrus (e) and adult testicles (T)
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or other diseases of the female reproduction system [16, 25,
32–34]. These studies might include local concentrations of
various steroids in multiple reproductive tissues, or perhaps
the effects of local application of P450 enzyme inhibitors.
Conclusions
Immunohistochemical analysis showed different sites of
expression of sex steroidogenic enzymes along with tis-
sue response throughout different phases of the estrous
cycle. Results also indicate that expression changes with
the stage of the cycle, both the levels and types of cells
exhibiting expression. Thus, changes in proliferation of
vaginal epithelial cells and the differentiation of the mu-
cosa may be influenced by local steroid synthesis as well
as circulating androgens and estrogens.
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